Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Issue: Health products
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 106 - 120 of 173 items.
GILENYA (fingolimod) - Risk of Congenital Malformations
AlertHealth professional risk communication | 2019-12-19
Alcohol, Cannabis and Drug Use During the Holiday Season
AlertInformation update | 2019-12-17
Health Canada evaluating NDMA in metformin drugs
AlertInformation update | 2019-12-05
XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis
AlertHealth professional risk communication | 2019-12-02
Unauthorized products may pose serious health risks (October 2, 2019 to November 19, 2019)
AlertPublic advisory | 2019-11-19
ULORIC ® (febuxostat) - Increased Risk of Cardiovascular Fatal Outcomes
AlertHealth professional risk communication | 2019-11-04
Foreign Product Alert: 24 foreign health products found to contain undeclared drug ingredients
AlertForeign product alert | 2019-10-18
LEMTRADA (alemtuzumab) - Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions
AlertHealth professional risk communication | 2019-10-15
Unauthorized Nabota botulinum toxin may pose serious health risks
AlertPublic advisory | 2019-09-30
Unauthorized products may pose serious health risks (August 12, 2019 to September 18, 2019)
AlertPublic advisory | 2019-09-18
Health Canada advises Canadians to exercise caution when taking gabapentin or pregabalin with opioids
AlertInformation update | 2019-09-17